Fatigue News and Research

RSS

$Adults with eczema at greater risk of accidental bone fractures, other injuries$

Adults with eczema at greater risk of accidental bone fractures, other injuries

Intense itching and dry, irritable skin aren't the only problems adults with eczema face. They are at greater risk of accidental bone fractures and other injuries, a new Northwestern Medicine® study has found.

31 Oct 2014

Pre-treatment pain intensity predicts survival of patients with head and neck cancer

Pre-treatment pain intensity is an independent survival predictor for patients with head and neck cancer, according to new research published in The Journal of Pain, the peer-reviewed publication of the American Pain Society.

28 Oct 2014

Pulmocide uses INTEGRA's VIAFLO Assist pipetting assistant to improve screening of novel compounds

INTEGRA reports on how respiratory drug discovery and development specialists - Pulmocide Ltd. (London, UK) are using a VIAFLO Assist pipetting assistant to enhance the productivity and reproducibility of their screening of novel compounds in a range of biological assays.

From INTEGRA Biosciences 28 Oct 2014

Sleep problems very common among young children receiving treatment for psychiatric disorders

John Boekamp, Ph.D., clinical director of the Pediatric Partial Hospital Program at Bradley Hospital recently led a study that found sleep difficulties - particularly problems with falling asleep - were very common among toddlers and preschool-aged children who were receiving clinical treatment for a wide range of psychiatric disorders.

27 Oct 2014

FDA accepts Eisai's sNDA for perampanel drug for treatment of PGTC seizures

Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted for review the company's Supplemental New Drug Application (sNDA) for its in-house-discovered AMPA receptor antagonist perampanel for the treatment of primary generalized tonic-clonic (PGTC) seizures.

20 Oct 2014

Boston Scientific starts PLATINUM Diversity trial to evaluate Promus PREMIER Stent System

As part of its commitment to innovation and improving patient outcomes, Boston Scientific Corporation has initiated the PLATINUM Diversity trial to evaluate the clinical performance of the Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System in underserved patient populations, including women and people of color.

20 Oct 2014

Janssen announces submission of IMBRUVICA sNDA to FDA for WM treatment

Janssen Research & Development, LLC today announced the submission of a supplemental New Drug Application (sNDA) for IMBRUVICA (ibrutinib) to the U.S. Food and Drug Administration by its strategic partner Pharmacyclics, Inc.

20 Oct 2014

The Female Athlete Triad: A medical condition in active girls and women

Sophie is a 15 year old cross country runner who has a history of a foot stress fracture and shin splints. Often she does not eat prior to her workouts.

17 Oct 2014

Myths, misconceptions about seasonal flu and flu vaccine

It's that time of year again. As days shorten, evenings become chilly and the trees start a showy display of color, it's time to roll up your sleeve and get your annual flu vaccine.

16 Oct 2014

Reducing heart failure deaths: an interview with Dimitrios Georgiopoulos, UK Medical Director, Novartis

Heart failure is a debilitating, and life-threatening, condition in which the heart cannot pump enough blood around the body. When heart failure continues to progress and worsen over time, the persistent condition is known as chronic heart failure.

From Novartis 16 Oct 2014

Leading UK supplier uses INTEGRA’s VIAFLO II, VIAFLO ASSIST to improve assay consistency

A leading UK supplier of early-stage drug discovery and development process services has improved the consistency and efficiency of its assays using VIAFLO II pipettes and a VIAFLO ASSIST from INTEGRA. By mounting a VIAFLO II electronic pipette on the VIAFLO ASSIST, the pipette’s protocols can be carried out fully automatically.

From INTEGRA Biosciences 15 Oct 2014

Leica Microsystems launches new neurosurgical microscope

Leica Microsystems has launched a new neurosurgical microscope, the Leica M530 OH6. To enable surgeons to see better into deep, narrow cavities, it is equipped with FusionOptics technology, advanced Small Angle Illumination (SAI) and apochromatic optics. The ergonomic design of the microscope enables surgeons and assistants to work in a neutral, upright posture which helps prevent strain and fatigue.

From Leica Microsystems GmbH 14 Oct 2014

New miniaturized, wireless monitoring system for heart failure patients

A new miniaturized, wireless monitoring system, implanted in the pulmonary artery, is helping keep patients with severe heart failure out of the hospital. Houston Methodist Hospital is the first institution in Houston to offer this to heart failure patients.

14 Oct 2014

New research shows impact of ulcerative colitis on patients' quality of life, treatment satisfaction

New research shows that the majority of patients with the challenging inflammatory bowel disease, ulcerative colitis (UC), state that the three biggest impacts of the disease on their lives are on their emotional state (in terms of depression, anger or anxiety levels) (76%), ability to get adequate rest/sleep (75%), and taking sick days off work (70%). Those who have had a colectomy (removal of the colon) were more likely to suffer from these impacts.

14 Oct 2014

Griffith researcher awarded $1.85m grant to accelerate diagnosis, treatment for CFS

Providing increased services for Chronic Fatigue Syndrome sufferers will be the focus of Griffith research following the award of a $1.85m grant to one of Australia’s foremost authorities on the condition.

14 Oct 2014

Eisai, Helsinn Group announce FDA approval of AKYNZEO for prevention of CINV

Helsinn Group and Eisai Inc. announced today that the Food and Drug Administration (FDA) approved AKYNZEO® for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.

13 Oct 2014

National Psoriasis Foundation to hold free psoriatic arthritis program in Seattle

If you're one of the roughly 28,000 Seattle metro residents struggling with pain from psoriatic arthritis (PsA)—an inflammatory autoimmune disease that causes pain, swelling and stiffness of the joints and tendons—learn to control your condition with Be Joint Smart, a free psoriatic arthritis program presented by the National Psoriasis Foundation, at the Double Tree Suites Southcenter on November 8.

13 Oct 2014

Research roundup: Older consumers' spending on health care; hospital leaders' views of reporting quality

In 2011, households with at least one member between ages 50 and 64 spent 8 percent of their total budget on health items, compared with 19 percent for those age 85 or over.

13 Oct 2014

Preoperative IV ibuprofen improves quality of recovery after laparoscopic cholecystectomy surgery

Cumberland Pharmaceuticals Inc. today announced that preoperative intravenous ibuprofen improved overall quality of recovery in patients undergoing laparoscopic cholecystectomy surgery. These results will be presented at the American Anesthesiology 2014 Annual Meeting in New Orleans, Louisiana.

12 Oct 2014

New method can reduce environmental impact caused by manufacturing processes

The human and environmental dangers posed by a widely used manufacturing technique could be almost eradicated thanks to research led by Plymouth University.

9 Oct 2014

Fatigue News and Research

Adults with eczema at greater risk of accidental bone fractures, other injuries

Pre-treatment pain intensity predicts survival of patients with head and neck cancer

Pulmocide uses INTEGRA's VIAFLO Assist pipetting assistant to improve screening of novel compounds

Sleep problems very common among young children receiving treatment for psychiatric disorders

FDA accepts Eisai's sNDA for perampanel drug for treatment of PGTC seizures

Boston Scientific starts PLATINUM Diversity trial to evaluate Promus PREMIER Stent System

Janssen announces submission of IMBRUVICA sNDA to FDA for WM treatment

The Female Athlete Triad: A medical condition in active girls and women

Myths, misconceptions about seasonal flu and flu vaccine

Reducing heart failure deaths: an interview with Dimitrios Georgiopoulos, UK Medical Director, Novartis

Leading UK supplier uses INTEGRA’s VIAFLO II, VIAFLO ASSIST to improve assay consistency

Leica Microsystems launches new neurosurgical microscope

New miniaturized, wireless monitoring system for heart failure patients

New research shows impact of ulcerative colitis on patients' quality of life, treatment satisfaction

Griffith researcher awarded $1.85m grant to accelerate diagnosis, treatment for CFS

Eisai, Helsinn Group announce FDA approval of AKYNZEO for prevention of CINV

National Psoriasis Foundation to hold free psoriatic arthritis program in Seattle

Research roundup: Older consumers' spending on health care; hospital leaders' views of reporting quality

Preoperative IV ibuprofen improves quality of recovery after laparoscopic cholecystectomy surgery

New method can reduce environmental impact caused by manufacturing processes

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News